Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zucman

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
European Journal of Public Health|February 27, 2024
Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults' cohort, France, 2006-18Alexandre Vallée, Catherine Majerholc, David Zucman, et al.
HIV Clinical Trials|July 10, 2013
Long-term HIV-1 virologic control in patients on a dual NRTI regimenThierry Prazuck, David Zucman, Véronique Avettand-Fènoël, et al.
Plos Pathogens|January 19, 2012
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaStéphanie Dupuy, Marion Lambert, David Zucman, et al.
American Journal of Health Behavior|November 5, 2022
Risk Prediction Score for Screening Asymptomatic Sexually Transmitted Infections in HIV-positive French Men Who Have Sex with Men (ANRS 9520 DRIVER)Martin Duracinsky, Svetlane Dimi, Maria Patrizia Carrieri, et al.
Pharmacology Research & Perspectives|September 10, 2020
Pharmacist's role in HIV care in France. Implication for clinical improvement of people living with HIV worldwideChristine Jacomet, Julie Langlois, Solene Secher, et al.
Therapeutic Advances in Infectious Disease|October 20, 2025
Patient-reported outcomes among people living with HIV switching to dual therapy with dolutegravir/lamivudine: results from the PROBI studyMartin Duracinsky, Tristan Alain, David Zucman, et al.
Plos One|June 24, 2021
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screeningEric Farfour, Svetlane Dimi, Olivier Chassany, et al.
AIDS Research and Treatment|October 13, 2025
Sex Differences in Patient-Reported Outcomes Among People Living With HIV Switching to an Oral Dual Therapy: Results From the PROBI StudyTristan Alain, Fabienne Marcellin, Pascal Bessonneau, et al.
Plos One|March 7, 2024
Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)Guillaume Roucoux, Frédérique Thonon, David Zucman, et al.
Plos One|September 25, 2020
De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on genericsJean-Stephane Giraud, Melanie Doisne, Aurelie Chan Hew Wai, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Public Health|February 27, 2024
Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults' cohort, France, 2006-18Alexandre Vallée, Catherine Majerholc, David Zucman, et al.
HIV Clinical Trials|July 10, 2013
Long-term HIV-1 virologic control in patients on a dual NRTI regimenThierry Prazuck, David Zucman, Véronique Avettand-Fènoël, et al.
Plos Pathogens|January 19, 2012
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaStéphanie Dupuy, Marion Lambert, David Zucman, et al.
American Journal of Health Behavior|November 5, 2022
Risk Prediction Score for Screening Asymptomatic Sexually Transmitted Infections in HIV-positive French Men Who Have Sex with Men (ANRS 9520 DRIVER)Martin Duracinsky, Svetlane Dimi, Maria Patrizia Carrieri, et al.
Pharmacology Research & Perspectives|September 10, 2020
Pharmacist's role in HIV care in France. Implication for clinical improvement of people living with HIV worldwideChristine Jacomet, Julie Langlois, Solene Secher, et al.
Therapeutic Advances in Infectious Disease|October 20, 2025
Patient-reported outcomes among people living with HIV switching to dual therapy with dolutegravir/lamivudine: results from the PROBI studyMartin Duracinsky, Tristan Alain, David Zucman, et al.
Plos One|June 24, 2021
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screeningEric Farfour, Svetlane Dimi, Olivier Chassany, et al.
AIDS Research and Treatment|October 13, 2025
Sex Differences in Patient-Reported Outcomes Among People Living With HIV Switching to an Oral Dual Therapy: Results From the PROBI StudyTristan Alain, Fabienne Marcellin, Pascal Bessonneau, et al.
Plos One|March 7, 2024
Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)Guillaume Roucoux, Frédérique Thonon, David Zucman, et al.
Plos One|September 25, 2020
De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on genericsJean-Stephane Giraud, Melanie Doisne, Aurelie Chan Hew Wai, et al.
Pageof 8